[Hormones and Mobility].

Area of Science:

• Endocrinology
• Mobility Science
• Metabolic Health

Background:

• Endocrine disorders like Cushing's syndrome and hyperparathyroidism directly impact skeletal and muscular tissues, affecting mobility.
• The endocrine system is integral to the development of (osteo)sarcopenia, a condition with significant prognostic implications across various diseases.
• Lack of physical activity is a key factor in metabolic disease development, carrying substantial individual and societal costs.

Purpose of the Study:

• To explore the multifaceted relationship between endocrine function and physical mobility.
• To highlight the role of the endocrine system in (osteo)sarcopenia and its impact on disease prognosis.
• To underscore the reciprocal relationship between physical activity and metabolic health.

Main Methods:

• Review of literature on endocrine disorders and their effects on musculoskeletal health.
• Analysis of the endocrine system's involvement in the pathophysiology of (osteo)sarcopenia.
• Examination of the impact of physical activity on metabolic disease development.

Main Results:

• Specific endocrine disorders have characteristic, hormone-mediated effects on skeletal and muscular tissues influencing mobility.
• The endocrine system's role in (osteo)sarcopenia is increasingly recognized as a critical factor in patient outcomes.
• Sedentary behavior is a significant contributor to metabolic diseases with severe health and economic consequences.

Conclusions:

• Understanding hormone-mediated effects is crucial for addressing mobility impairments in endocrine disorders.
• Targeting endocrine pathways and promoting physical activity are essential for managing (osteo)sarcopenia and metabolic diseases.
• Integrated approaches considering hormonal balance and physical activity are necessary for comprehensive patient care and disease prevention.